Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Clinical trial NCT01999868 · COMPLETED
Trial details
- NCT number
- NCT01999868
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-19
- Primary completion
- 2017-12-07
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.